This report presents an overview of the patterns of liver injury produced by presently recognized toxic substances in the environment. Current concepts of the metabolic disposition of these substances in the liver suggest that their toxic effects may be modulated by an interplay between enzymatic pathways for activation or inactivation of foreign compounds. A better understanding of the genetic control of the enzymes involved in these pathways, as well as the mechanisms of cell death or malignancy produced by the products of these pathways, is needed. Although a number of sensitive biochemical tests of liver function are currently available, development of specific, noninvasive screening tests for the earliest manifestations of liver injury are urgently needed.
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The liver plays a central role in mediating the interaction between man and his chemical environment. The liver is not only a target organ for toxic effects of many environmental substances, but also the major site for biotransformation of foreign chemicals that enter the body. A list of the patterns of liver toxicity produced by noninfectious conditions other than therapeutic agents is presented in Table 1 (1-3). Some industrial chemicals or contaminants naturally found in food products regularly produced dose-dependent hepatic necrosis. Cholestasis, when appearing as the sole manifestation of liver injury, is rare (4) . Liver injury due to environmental agents is often nonspecific and inconspicuous. This presents a challenge to the clinician or epidemiologist in establishing a cause-and-effect relationship between a contact with an environmental agent and liver toxicity. Examples include fatty metamorphosis detected only by liver biopsy, or hypertrophy of the endoplasmic reticulum (microsome induction). In the United States, venoocclusive disease, granulomas, or hepatoportal fibrosis have been associated only with a limited number of toxic substances. Cirrhosis has been found in industrial workers exposed to chlorinated organic compounds or to plant toxins, but this, too, has been observed only infrequently. Figure 1 . Most often, environmental agents are lipophilic and, hence, are not readily excreted in aqueous media such as urine or bile. Hepatic metabolism converts these substances to more polar, readily excretable forms. induction. There is substantial evidence in animals and growing evidence in man that the amounts of cytochrome P-450 and its inducibility are under genetic control (11) . The level of cytochrome P-450 may be decreased in many physiologic or pathophysiologic states (12) . Remarkable progress has been made over the last 15 years in isolating and characterizing these hemoproteins and in understanding their regulation in the liver. As with the cytochrome P-450 system, there is intense interest in elucidating these conjugating enzymes which include cytoplasmic glutathione-S-transferases, and microsomal glucuronyl transferases and epoxide hydratases. Future support should be given to efforts to characterize the structure and regulation of cytochrome(s) P The problems of extrapolation from experimental animals to humans are perhaps nowhere better illustrated than in the subject of hepatocellular carcinoma. Despite the fact that many persistent chemicals in the environment cause liver tumors when administered at high doses to experimental animals, it is as yet unknown whether or not organochlorine pesticides, polyhalogenated biphenyls, etc., also produce cancer in humans exposed chronically to small amounts of these substances. Investigation of this problem in humans is difficult because the latent period for emergence of human malignancy is long, and because epidemiology is a relatively insensitive tool for establishing causation in human carcinogenesis unless the tumor is rare or unless the carcinogen is extremely potent. Solving this problem will undoubtedly require a combined approach using improved methods for clinical inves (19) (20) (21) (22) (23) . The liver is solely responsible for the synthesis and enterohepatic recirculation of bile acids. Therefore, biliary obstruction, hepatocellular necrosis, loss in functioning mass of the liver due to fibrosis, or extrahepatic shunts will decrease the (24) . The administered parent drug is labeled with a radioactive or stable isotope and the labeled metabolite, CO2, is collected with a breath-trapping device. The test appears to be somewhat less sensitive than the transaminases due to wide overlap in the range of normal values, but nevertheless is useful for reflecting microsome hypertrophy of the endoplasmic reticulum (microsome induction). These tests may reflect the amount of functioning liver mass and, therefore, are particularly useful for repeatedly examining changes in liver function over time in a given individual (25) . Induction of the endoplasmic reticulum of the liver has also been monitored by the urinary excretion of glucaric acid, a breakdown product of microsomal glucuronic acid (26) (27) (28) (29) , or by urinary excretion of 6,B-hydroxycortisol (30) , a product of endogenous steroid oxidation in the liver. Many environmental agents evoke hypertrophy of the endoplasmic reticulum as their sole hepatic manifestation. It should be emphasized that it is unknown as yet whether this should be termed a toxic or an adaptive response of the liver. From the preceding discussion, it may be seen that induction of hepatic microsomal enzymes could have either a favorable or an unfavorable effect (31) . Although tests for hepatic microsomal enzyme induction have been restricted largely to clinical pharmacologic studies of drugs, they may have wider application for problems of environmental chemicals. Therefore, it would be desirable to develop even more sensitive and specific tests for this purpose.
a-Fetoprotein is a serum test for the presence of hepatoma (32) . Recently, the sensitivity of the test has been greatly improved by the development of a radioimmunoassay (33, 34) . This test provides the earliest practical marker of hepatoma and is useful for following the development of the tumor. Minor elevations of a-fetoprotein occur with metastatic tumors to the liver and also in nonneoplastic liver disease (35) .
A potential problem with screening large populations with liver tests is that abnormalities may be produced by factors other than exposure to the toxic substance under investigation. Prominent among these in Western societies is ethanol. Regular consumption even of modest amounts of ethanol can produce abnormalities in one or more of the tests listed in Table 2 . Histories ofthe amount of ethanol consumed are notoriously unreliable. Screening tests that have been used for estimating the presence and amount of ethanol consumption include AST/ALT ratio and -y-glutamyl transpeptidase (GGTP). A simple and efficient test that could be incorporated in large-scale screening protocols is estimation of the ratio of the AST to ALT. Characteristically, ethanol consumption preferentially increases the AST, while the ALT remains normal or significantly less elevated (36) (37) (38) (39) (40) (41) . A second test that has been reported to be elevated in 60-90% of populations regularly consuming ethanol is the serum GGTP (42). More specialized tests currently under investigation include the presence of an abnormal amount of serum *transferin (43) , plasma urate concentration (44) , and the presence of macrocytosis (44) .
We presently lack biochemical or morphologic markers of the carcinogenic process during the long latent period between contact with a carcinogen and the emergence of hepatocellular cancers. 
